Minerva Surgical, Inc.
UTRS · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $12 | $13 | $13 | $14 |
| % Growth | -10.6% | 6.8% | -9.2% | – |
| Cost of Goods Sold | $6 | $6 | $6 | $6 |
| Gross Profit | $6 | $7 | $7 | $7 |
| % Margin | 52% | 55.3% | 56% | 53.4% |
| R&D Expenses | $1 | $1 | $2 | $1 |
| G&A Expenses | $4 | $4 | $5 | $2 |
| SG&A Expenses | $11 | $14 | $16 | $11 |
| Sales & Mktg Exp. | $7 | $9 | $10 | $9 |
| Other Operating Expenses | $0 | -$0 | -$0 | -$0 |
| Operating Expenses | $12 | $15 | $17 | $13 |
| Operating Income | -$6 | -$8 | -$10 | -$5 |
| % Margin | -50.9% | -57.2% | -82.3% | -37.6% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$1 |
| Pre-Tax Income | -$7 | -$9 | -$11 | -$6 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7 | -$9 | -$13 | -$6 |
| % Margin | -60% | -64.8% | -107.3% | -45.2% |
| EPS | -0.81 | -0.98 | -2.81 | -2.01 |
| % Growth | 17.3% | 65.1% | -39.8% | – |
| EPS Diluted | -0.81 | -0.98 | -2.81 | -2.01 |
| Weighted Avg Shares Out | 9 | 9 | 5 | 3 |
| Weighted Avg Shares Out Dil | 9 | 9 | 5 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $2 | $0 | -$0 |
| EBITDA | -$5 | -$6 | -$10 | -$5 |
| % Margin | -38.1% | -41.3% | -81.7% | -37.7% |